WIN-Partners Co., Ltd.
3183
Rank in Stocks
#16245
Established in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd.... Established in 1973 and headquartered in Tokyo, Japan, WIN-Partners Co., Ltd. leverages its subsidiaries to distribute a comprehensive range of medical devices to healthcare institutions, primarily across Japan. Its diverse product offerings include cutting-edge cardiovascular tools such as percutaneous transluminal coronary angioplasty balloon catheters, drug-eluting stents, and intravascular ultrasound catheters. The company also supplies devices for cardiac rhythm management, like pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators, and ablation catheters. Furthermore, WIN-Partners provides structural and peripheral vascular products, including stent grafts, transcatheter heart valves, mechanical heart valves, and various stents and embolic coils. Rounding out its portfolio are diabetes management systems such as insulin pumps and continuous glucose monitoring devices, in addition to magnetic resonance imaging equipment.
Share Price
$7.98
Last synced: 2026-11-10
Market Cap
$219.31M
Change (1 day)
-0.79%
Change (1 year)
-3.86%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade WIN-Partners Co., Ltd. (3183)
Category
Healthcare
Operating Margin for WIN-Partners Co., Ltd. (3183)
Operating Margin as of November 2026 TTM: 3.16%
According to WIN-Partners Co., Ltd.'s latest financial reports, its current operating margin (TTM) is 3.16%. At the end of 2025 the company had an operating margin of 3.45%.
Operating Margin history for WIN-Partners Co., Ltd. from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 3.16% | -8.41% |
| 2025 | 3.45% | 1.17% |
| 2024 | 3.41% | -2.29% |
| 2023 | 3.49% | -16.11% |
| 2022 | 4.16% | 14.60% |
| 2021 | 3.63% | -11.68% |
| 2020 | 4.11% | -11.99% |
| 2019 | 4.67% | -6.60% |
| 2018 | 5.00% | -5.66% |
| 2017 | 5.30% | -3.28% |
| 2016 | 5.48% | 6.61% |
| 2015 | 5.14% | 3.21% |
| 2014 | 4.98% | 8.50% |
| 2013 | 4.59% | -8.20% |
| 2012 | 5.00% | 1.01% |
| 2011 | 4.95% | -3.70% |
| 2010 | 5.14% | 12.23% |
| 2009 | 4.58% | -9.84% |
| 2008 | 5.08% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 1.62% | -99.49% |
US
|
|
| 1.30% | -99.59% |
US
|
|
| 1.03% | -99.67% |
US
|
|
| 0.91% | -99.71% |
US
|
|
| 9.21% | -97.09% |
AU
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about WIN-Partners Co., Ltd.'s operating margin
What is WIN-Partners Co., Ltd.'s operating margin?
WIN-Partners Co., Ltd.'s operating margin is 3.16%, as of Nov 2026.
What was WIN-Partners Co., Ltd.'s operating margin in 2025?
In 2025, WIN-Partners Co., Ltd.'s operating margin was 3.45%, compared with 3.41% in 2024.
How has WIN-Partners Co., Ltd.'s operating margin changed since 2020?
From 2020 to 2025, WIN-Partners Co., Ltd.'s operating margin was highest in 2022 (4.16%) and lowest in 2024 (3.41%).
How does WIN-Partners Co., Ltd.'s operating margin compare with similar companies?
WIN-Partners Co., Ltd.'s operating margin (3.16%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Sigma Healthcare Limited, with 9.21%.